ProPhase Labs, Inc. - COM (PRPH)

Historical Holders from Q1 2014 to Q3 2025

Symbol
PRPH on Nasdaq
Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2,980,665
Holdings value
$1,364,315
% of all portfolios
0%
Number of holders
28
Number of buys
11
Number of sells
-14
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ProPhase Labs, Inc. - COM (PRPH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2,980,665 $1,364,315 +$165,130 $0.4578 28
2025 Q2 2,677,959 $1,047,801 -$943,685 $0.3913 32
2025 Q1 4,994,564 $2,017,465 +$975,389 $0.4043 37
2024 Q4 2,418,755 $1,914,045 +$424,137 $0.7571 30
2024 Q3 1,748,646 $4,231,836 -$124,172 $2.42 25
2024 Q2 1,738,576 $7,268,094 +$76,709 $4.18 28
2024 Q1 1,696,125 $10,972,560 +$115,601 $6.47 29
2023 Q4 1,645,317 $7,436,314 -$1,105,758 $4.52 24
2023 Q3 1,959,864 $8,563,439 -$2,210,415 $4.37 35
2023 Q2 2,175,452 $15,794,059 -$2,005,490 $7.26 45
2023 Q1 2,442,921 $18,601,004 -$3,082,162 $7.62 39
2022 Q4 2,775,902 $26,744,280 -$165,852 $9.63 51
2022 Q3 2,685,273 $30,280,000 +$8,111,357 $11.28 45
2022 Q2 1,950,655 $24,751,000 +$5,389,415 $12.68 38
2022 Q1 1,398,960 $9,789,000 +$179,270 $7 20
2021 Q4 1,373,156 $9,843,000 -$1,284,171 $7.17 21
2021 Q3 1,646,966 $8,560,000 +$118,587 $5.2 21
2021 Q2 1,604,593 $9,946,000 +$1,564,920 $6.2 23
2021 Q1 1,294,139 $9,567,000 +$6,028,748 $7.39 27
2020 Q4 475,528 $4,365,000 +$215,296 $9.18 14
2020 Q3 425,296 $1,472,000 +$26,220 $3.46 8
2020 Q2 428,865 $616,000 -$82,301 $1.44 9
2020 Q1 516,056 $975,000 +$26,266 $1.89 11
2019 Q4 502,782 $989,000 -$2,287 $1.97 11
2019 Q3 503,122 $964,000 -$23,801 $1.92 11
2019 Q2 513,096 $1,101,000 -$9,971 $2.15 14
2019 Q1 510,174 $1,535,000 +$60,587 $3.01 13
2018 Q4 489,054 $1,539,000 -$114,186 $3.15 12
2018 Q3 526,832 $1,580,000 +$53,843 $3 13
2018 Q2 508,833 $1,653,000 +$260,463 $3.25 12
2018 Q1 429,760 $1,273,000 +$107,206 $2.96 11
2017 Q4 396,295 $861,000 -$1,432,231 $2.18 10
2017 Q3 1,066,850 $2,282,000 -$148,086 $2.14 11
2017 Q2 1,138,503 $2,380,000 +$204,976 $2.09 16
2017 Q1 1,046,295 $2,376,000 -$18,058 $2.27 10
2016 Q4 1,061,598 $2,123,000 +$46,464 $2 11
2016 Q3 1,038,187 $2,039,000 -$3,064 $1.96 10
2016 Q2 1,117,290 $1,461,000 -$79,420 $1.31 13
2016 Q1 1,178,224 $1,588,000 -$1,045,723 $1.4 12
2015 Q4 1,875,670 $2,815,000 +$11,785 $1.5 14
2015 Q3 1,845,431 $2,951,000 +$38,376 $1.58 12
2015 Q2 1,827,584 $2,467,000 -$8,666 $1.35 12
2015 Q1 1,797,773 $2,353,000 -$19,316 $1.31 13
2014 Q4 1,859,889 $2,712,000 +$928,142 $1.46 14
2014 Q3 1,238,206 $1,732,000 +$94,891 $1.4 14
2014 Q2 1,157,095 $1,956,000 -$14,171 $1.69 11
2014 Q1 1,165,213 $2,326,000 +$13,590 $2 9